Universal FLU-v Influenza Vaccine, Immunogenic and Warrants Further Testing
The adjuvanted, broad-spectrum influenza vaccine FLU-v was found to be immunogenic and merits phase 3 development to explore efficacy.
Influenza
Addressing Parents’ Concerns Improves Influenza Immunization Rates
Implementation of an influenza immunization program increased vaccinations rates from 44% to 57% the following year.
Evaluation of Trivalent vs Quadrivalent Inactivated Vaccine for Influenza B
Despite the higher effectiveness of the quadrivalent inactivated influenza vaccine against the added B virus lineage, trivalent inactivated influenza vaccine.
Vaccine Effectiveness 45% for Flu Virus Linked to ARI
The overall vaccine effectiveness against any influenza virus associated with medically attended ARI is 45% for the current season.
Wearable Device Data May Help Predict Flu-Like Illness Patterns
Fitbit data significantly improved prediction of influenza-like illness in top 5 states with most users.
Oseltamivir Reduces Recovery Time for Flu-Like Illness in European Study
Oseltamivir may reduce recovery time for primary care patients with influenza-like illness, especially for older, sicker patients with comorbidities.
Pneumococcal Vaccine in Older Adults: A Primary Care Approach to Increasing Uptake
Because of low vaccination rates, approximately 5.6 million cases of community-acquired pneumonia occur in the United States annually.
Too Few Women Receive Influenza and Tdap Vaccines During Pregnancy, CDC Says
Only 1 in 3 mothers-to-be receive both influenza and Tdap vaccines, according to a CDC report.
AHA: About 1 in 3 With ASCVD Not Receiving Flu Shot
Vaccine coverage significantly lower among non-Hispanic blacks, those with lower education, income.
CHEST: Flu Shots Benefit Patients Hospitalized With Pneumonia
Study shows that in-hospital influenza vaccination may lower costs, risk for readmission or death.
Next post in Pulmonology Information Center
